Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05319080 · ClinicalTrials.gov registry record · NA
Individualized Repetitive Transcranial Magnetic Stimulation for Auditory Verbal Hallucinations
A NA study, sponsored by Columbia University.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT05319080 is a NA study that was terminated before completion, run by Columbia University. The registered enrollment target is 11 participants.
The verdict
NCT05319080, a NA study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The Repetitive Transcranial Magnetic Stimulation (rTMS) is a type of brain stimulation that uses a magnet to change activity in the brain. rTMS uses magnetic pulses to induce an electrical current in the brain to alter brain activity and function in specific areas. For example, stimulating the part of the brain controlling movement will cause parts of the foot or leg to twitch. TMS is proposed as a novel treatment for people with schizophrenia. The investigators want to see if low frequency rTMS can lessen some of the symptoms of schizophrenia, specifically auditory verbal hallucinations. Auditory verbal hallucinations describe the experience of hearing voices that are not really there.
Interventions
- DEVICE Repetitive Transcranial Magnetic Stimulation (rTMS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2023-04-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05319080
The ClinicalTrials.gov registry entry for NCT05319080 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Repetitive Transcranial Magnetic Stimulation (rTMS) is the first listed.
NCT05319080 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05319080 about?
NCT05319080 is a clinical study titled "Individualized Repetitive Transcranial Magnetic Stimulation for Auditory Verbal Hallucinations". The Repetitive Transcranial Magnetic Stimulation (rTMS) is a type of brain stimulation that uses a magnet to change activity in the brain. rTMS uses magnetic pulses to induce an electrical current in the brain to alter brain activity and function in specific areas. For example, stimulating the part ...
What is the current status of trial NCT05319080?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2022-08-01. Estimated completion is 2023-04-07.
What interventions are being tested in trial NCT05319080?
The interventions under investigation include: Repetitive Transcranial Magnetic Stimulation (rTMS) (DEVICE).
Who is sponsoring clinical trial NCT05319080?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.